Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Vladimir Zharov
Univ of Arkansas for Med Scis, Department: Otolaryngology
Should you be removed from our database? Contact us at [email protected]. Read more below.
CytoAstra, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The Investigator has a proprietary interest in technology that is licensed to CytoAstra, LLC as well as an equity interest in CytoAstra, LLC, and performs research that has the potential to affect the the value of this interest.
Interaction of gold nanoparticles with lymphatic vessels
PROJECT NARRATIVE Invasion of living organism by nanoparticles (NPs) suggests interaction between nanomaterials and biological systems, synthetic and the organic worlds, which may impair cell and organ function and even cause pathological disorders. After administration in the organism, NPs are commonly disseminated by blood and lymph streams, directly contact with the inner endothelial lining of blood and lymph vessels, and may alter the function of endothelial cells. While the interactions of NPs and blood endothelial cells have intensively studied in recent years, the effect of NPs on lymphatic endothelial cells and, eventually, on lymphatic function remains unexplored territory. We propose to remedy that defect in this project with goal to understand interaction between lymphatic system and commonly used gold nanoparticles.
Filed on November 26, 2018.
Tell us what you know about Vladimir Zharov's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Vladimir Zharov”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Vladimir Zharov | Univ of Arkansas for Med Scis | Conflict of Interest | Photoacoustic Cytometry | $0 - $4,999 |
| Vladimir Zharov | Univ of Arkansas for Med Scis | Conflict of Interest | CytoAstra, LLC | Value cannot be readily determined |
| Vladimir Zharov | Univ of Arkansas for Med Scis | Conflict of Interest | CytoAstra, LLC | Value cannot be readily determined |
| Vladimir Zharov | Univ of Arkansas for Med Scis | Conflict of Interest | CytoAstra, LLC | Value cannot be readily determined |
| Vladimir Zharov | Univ of Arkansas for Med Scis | Conflict of Interest | CytoAstra, LLC | Value cannot be readily determined |
| Vladimir Zharov | Univ of Arkansas for Med Scis | Conflict of Interest | CytoAstra, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.